
Reset all filters
01 1Pfizer Inc
Reset all filters
01 1U.S.A
Reset all filters
01 1Blank
01 1Expired
Reset all filters
01 1Blank
Reset all filters
01 1Blank
Reset all filters
01 1Blank
Reset all filters
01 1Blank
01 1Blank
Certificate Number : R0-CEP 2000-355 - Rev 00
Issue Date : 2002-08-02
Type : TSE
Substance Number : 2243
Status : Expired
51
PharmaCompass offers a list of Tirilazad API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tirilazad manufacturer or Tirilazad supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tirilazad manufacturer or Tirilazad supplier.
PharmaCompass also assists you with knowing the Tirilazad API Price utilized in the formulation of products. Tirilazad API Price is not always fixed or binding as the Tirilazad Price is obtained through a variety of data sources. The Tirilazad Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tirilazad manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tirilazad, including repackagers and relabelers. The FDA regulates Tirilazad manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tirilazad API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tirilazad supplier is an individual or a company that provides Tirilazad active pharmaceutical ingredient (API) or Tirilazad finished formulations upon request. The Tirilazad suppliers may include Tirilazad API manufacturers, exporters, distributors and traders.
click here to find a list of Tirilazad suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.